Bridgeway Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$390K	Sell	117,700 -50,000	-30%	-$166K	0.01%	816
2025 Q1	$486K	Buy	+167,700	New	+$486K	0.01%	749
2024 Q4	–	Sell	-192,856	Closed	-$960K	–	1202
2024 Q3	$960K	Hold	192,856	–	–	0.02%	700
2024 Q2	$501K	Hold	192,856	–	–	0.01%	858
2024 Q1	$822K	Hold	192,856	–	–	0.02%	792
2023 Q4	$390K	Buy	192,856 +45,000	+30%	+$90.9K	0.01%	1002
2023 Q3	$226K	Hold	147,856	–	–	0.01%	1074
2023 Q2	$244K	Buy	147,856 +4,900	+3%	+$8.09K	0.01%	1090
2023 Q1	$163K	Hold	142,956	–	–	﹤0.01%	1137
2022 Q4	$129K	Hold	142,956	–	–	﹤0.01%	1181
2022 Q3	$167K	Sell	142,956 -61,400	-30%	-$71.7K	﹤0.01%	1170
2022 Q2	$131K	Sell	204,356 -64,200	-24%	-$41.2K	﹤0.01%	1175
2022 Q1	$701K	Buy	268,556 +85,556	+47%	+$223K	0.01%	859
2021 Q4	$712K	Hold	183,000	–	–	0.01%	876
2021 Q3	$798K	Buy	183,000 +56,000	+44%	+$244K	0.02%	888
2021 Q2	$504K	Sell	127,000 -25,000	-16%	-$99.2K	0.01%	1061
2021 Q1	$790K	Hold	152,000	–	–	0.01%	947
2020 Q4	$813K	Buy	152,000 +33,100	+28%	+$177K	0.02%	791
2020 Q3	$577K	Buy	118,900 +38,400	+48%	+$186K	0.01%	835
2020 Q2	$391K	Hold	80,500	–	–	0.01%	943
2020 Q1	$176K	Buy	80,500 +5,500	+7%	+$12K	﹤0.01%	1092
2019 Q4	$437K	Buy	75,000 +15,000	+25%	+$87.4K	0.01%	1036
2019 Q3	$191K	Hold	60,000	–	–	﹤0.01%	1189
2019 Q2	$252K	Sell	60,000 -37,000	-38%	-$155K	﹤0.01%	1136
2019 Q1	$670K	Buy	+97,000	New	+$670K	0.01%	910